Skip to content

GM-CSF Programs Alveolar Macrophages to Maintain Pulmonary Lymphocyte Homeostasis

Oct 2026 · bioRxiv · 0 citations · 43 references
Biology

TL;DR

This work identifies granulocyte-macrophage colony-stimulating factor (GM-CSF) as a central regulator of pulmonary lymphocyte homeostasis and identifies alveolar macrophages as gatekeepers of adaptive immune homeostasis in the lung.

View source

Similar papers

Open access Oct 2026

Neutrophils and CSF1 promote the expansion of monocyte-derived alveolar macrophages in progressive pulmonary fibrosis.

Progressive pulmonary fibrosis (PPF) is a fatal lung condition characterized by persistent inflammation and progressive fibrotic remodeling. Monocyte-derived alveolar macrophages (Mo-AMs) are key drivers of fibrogenesis; however, the mechanisms underlying their persistence in fibrotic lungs remain unclear. Using lineag...

K. Kase, Satoshi Watanabe, Masafumi Horie et al. · 0 citations
Open access Sep 2026

Macrophage polarization modulates neutrophil extracellular trap dynamics and reciprocal macrophage responses

The interplay between neutrophils and macrophages is central to inflammatory regulation, yet how macrophage polarization governs the homeostasis of neutrophil extracellular traps (NETs) remains poorly understood. Here, we show that the macrophage polarizing environment is a critical determinant of NETs dynamics in huma...

Laura Blum, Kira Jäger, Makenzie Jones et al. · 0 citations
Oct 2026

Arterial Resident But Not Monocyte-Derived Macrophages Require Endothelial CSF1.

BACKGROUND Tissue-resident macrophages (T-RMøs) accumulate at sites predisposed to atherosclerosis in the healthy aortic intima. T-RMøs require local cues for their maintenance, but the niche signals governing their persistence in arterial tissue remain poorly defined. Here, we identify distinct, spatially compartmenta...

Marwan G. Althagafi, Hisham M. Ibrahim, S. Hyduk et al. · 0 citations
Sep 2026

Pathological Th2 cell activation via STAT6 pathway for pulmonary fibrosis.

A CD28-JAK1/STAT6-Th2-monocyte-derived alveolar macrophage pathway is defined as a mechanistic driver of pulmonary fibrosis and nominate CD28 and STAT6 as actionable immunologic targets that could complement existing antifibrotic therapies.

Yudai Miyashita, T. Kaiho, Raul Piseaux Aillon et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.